Poster Abstract Session:
215. Antimicrobial Stewardship: Outpatient Parenteral Antibiotic Therapy
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Pediatric ID, Adult ID

Presentations:
Clinical Effectiveness of an ID Supervised Outpatient Parenteral Antibiotic Therapy Program
Nathan Skorodin, PharmD ; Russell Petrak, MD, FIDSA, FSHEA ; Robert Fliegelman, DO ; David W. Hines, MD
Posters
  • HAP Poster 2015 Total Final.pdf (740.2 kB)
  • Complications of Home Central Venous Catheters and Home-based Outpatient Parenteral Antimicrobial Therapy: A Prospective Study
    Sara Keller, MD, MPH, MSHP ; Sara Cosgrove, MD, MS, FIDSA, FSHEA ; Trish M. Perl, MD, MSc, FIDSA, FSHEA ; Kathleen Pulice, BS ; Mitra Gavgani, PharmD ; David Hirsch, RN ; Deborah Williams, RN
    Posters
  • Poster IDWeek 2015.pdf (245.7 kB)
  • Factors associated with failure of Outpatient Parenteral Antibiotic Therapy (OPAT)
    Sunjit Jaspal, MD ; Marie Dimattia, MD ; Christopher Bruno, MD ; Dong Heun Lee, MD
    Outpatient Ertapenem Therapy: Efficacy, Safety and Cost in a high prevalence ESBL-producing Enterobacteriaceae setting
    Arturo Ortiz Alvarez, RESIDENT ; Patricia Rodriguez Zulueta, Internal Medicine Physician ; Monica Alejandra Delgado Ramirez, MD ; Daniel Aguilar-Zapata, MD ; Rafael Valdez-Vazquez, MD ; Montserrat Cuevas, MEDICAL STUDENT
    Review of Treatment Failures in an ID Supervised Outpatient Parenteral Antibiotic Therapy Program
    Nathan Skorodin, PharmD ; Russell Petrak, MD, FIDSA, FSHEA ; David W. Hines, MD ; Robert Fliegelman, DO
    Pharmacist Monitoring in an OPAT Program Can Lead to a Reduction in 30 Day Readmission Rates
    Kathleen Sheridan, DO ; Ryan K. Shields, PharmD ; Bonnie Falcione, PharmD, BCPS AQ-ID ; Thomas Glowa, PharmD
    Posters
  • IDSA OPAT POSTER Sheridan.pdf (644.1 kB)
  • Pharmacoeconomic Analysis to Compare Dalbavancin and Vancomycin in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Population
    Brittany Andruszko, PharmD ; Tina Khadem, PharmD ; Jeff Huntress, PharmD ; Erica Dobson, PharmD ; Elizabeth Dodds Ashley, PharmD, MHS
    Experience and Outcomes After a Year of Implementation of a Program for Outpatient Parenteral Antimicrobial Therapy in a Tertiary Care Hospital in Mexico City
    Erika Faride Rodriguez Aguilar, MD ; Yemil Atisha-Fregoso, MD ; Alfredo Ponce De Leon-Garduño, MD ; José Sifuentes-Osornio, MD, FIDSA
    A 2-Year Analysis of 30-Day Hospital Readmissions and Cost Benefits of Septicemia Outpatient Treatment in a Physician Office Infusion Center (POIC)
    Barry Statner, MD, FRCPC, FIDSA ; Fernando S. Alvarado, MD, MPH & TM ; Brian Metzger, MD, MPH ; Richard M. Mandel, MD, FIDSA ; Jorge R. Bernett, MD ; H. Barry Baker, MD, FACP ; Alfred E. Bacon, III, MD ; Claudia P. Schroeder, PharmD, PhD ; Lucinda J. Van Anglen, PharmD
    Impact of an Infectious Diseases Transitions Service on Outcomes in Patients Discharged on Parenteral Antibiotics Requiring Therapeutic Drug Monitoring
    Julianne Gardner, PharmD ; Jillian Dougherty, PharmD ; Daniel Timko, PharmD, BCPS, AQID ; Shawn Binkley, BS, PharmD ; Steven Morgan, PharmD, BCPS, AQID ; Valerie Cluzet, MD ; David Pegues, MD, FIDSA, FSHEA ; Keith Hamilton, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.